These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32041716)

  • 21. Mycobacterium abscessus l,d-Transpeptidases Are Susceptible to Inactivation by Carbapenems and Cephalosporins but Not Penicillins.
    Kumar P; Chauhan V; Silva JRA; Lameira J; d'Andrea FB; Li SG; Ginell SL; Freundlich JS; Alves CN; Bailey S; Cohen KA; Lamichhane G
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28760902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRISPR Inhibition of Essential Peptidoglycan Biosynthesis Genes in Mycobacterium abscessus and Its Impact on β-Lactam Susceptibility.
    Kurepina N; Chen L; Composto K; Rifat D; Nuermberger EL; Kreiswirth BN
    Antimicrob Agents Chemother; 2022 Apr; 66(4):e0009322. PubMed ID: 35311518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of Oritavancin and Its Synergy with Other Antibiotics against
    Wang G; Tang J; Feng J; Dong W; Huo X; Lu H; Wang C; Lu W; Wang X; Chen H; Tan C
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controlling Extra- and Intramacrophagic
    Viljoen A; Herrmann JL; Onajole OK; Stec J; Kozikowski AP; Kremer L
    Front Cell Infect Microbiol; 2017; 7():388. PubMed ID: 28920054
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay.
    Portell-Buj E; Bonet-Rossinyol Q; López-Gavín A; Roman A; Fernández-Pittol M; Tudó G; Gonzalez-Martin J
    J Antibiot (Tokyo); 2021 Apr; 74(4):285-290. PubMed ID: 33420382
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in
    Raynaud C; Daher W; Johansen MD; Roquet-Banères F; Blaise M; Onajole OK; Kozikowski AP; Herrmann JL; Dziadek J; Gobis K; Kremer L
    ACS Infect Dis; 2020 Feb; 6(2):324-337. PubMed ID: 31860799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex.
    Takei S; Ihara H; Togo S; Nakamura A; Fujimoto Y; Watanabe J; Kurokawa K; Shibayama K; Sumiyoshi I; Ochi Y; Iwai M; Okabe T; Chonan M; Misawa S; Ohsaka A; Takahashi K
    BMC Microbiol; 2020 Oct; 20(1):316. PubMed ID: 33076820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus.
    Lopeman RC; Harrison J; Rathbone DL; Desai M; Lambert PA; Cox JAG
    Sci Rep; 2020 Jan; 10(1):928. PubMed ID: 31988293
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Auranofin Activity Exposes Thioredoxin Reductase as a Viable Drug Target in
    Ruth MM; van Rossum M; Koeken VACM; Pennings LJ; Svensson EM; Ruesen C; Bowles EC; Wertheim HFL; Hoefsloot W; van Ingen J
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action.
    Dousa KM; Nguyen DC; Kurz SG; Taracila MA; Bethel CR; Schinabeck W; Kreiswirth BN; Brown ST; Boom WH; Hotchkiss RS; Remy KE; Jacono FJ; Daley CL; Holland SM; Miller AA; Bonomo RA
    mBio; 2022 Feb; 13(1):e0352921. PubMed ID: 35073757
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Shen Y; Wang X; Jin J; Wu J; Zhang X; Chen J; Zhang W
    Biomed Res Int; 2018; 2018():4902941. PubMed ID: 30687747
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Recchia D; Stelitano G; Stamilla A; Gutierrez DL; Degiacomi G; Chiarelli LR; Pasca MR
    Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36902066
    [No Abstract]   [Full Text] [Related]  

  • 34.
    Martins O; Lee J; Kaushik A; Ammerman NC; Dooley KE; Nuermberger EL
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0154521. PubMed ID: 34516254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of Bedaquiline, Alone or in Combination with Imipenem, against Mycobacterium abscessus in C3HeB/FeJ Mice.
    Le Moigne V; Raynaud C; Moreau F; Dupont C; Nigou J; Neyrolles O; Kremer L; Herrmann JL
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32253217
    [No Abstract]   [Full Text] [Related]  

  • 36. Synergistic effects of sulopenem in combination with cefuroxime or durlobactam against
    Dousa KM; Shin E; Kurz SG; Plummer M; Nantongo M; Bethel CR; Taracila MA; Nguyen DC; Kreiswith BN; Daley CL; Remy KE; Holland SM; Bonomo RA
    mBio; 2024 Jun; 15(6):e0060924. PubMed ID: 38742824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex.
    Singh S; Bouzinbi N; Chaturvedi V; Godreuil S; Kremer L
    Clin Microbiol Infect; 2014 Dec; 20(12):O1124-7. PubMed ID: 25185732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
    Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
    Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach.
    Liu Y; Tan Y; Islam MM; Cao Y; Lu X; Zeng S; Hameed HMA; Zhou P; Cai X; Wang S; Mugweru JN; Zhang G; Yin H; Liu J; Nuermberger E; Zhang T
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31843996
    [No Abstract]   [Full Text] [Related]  

  • 40. Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus.
    Kaushik A; Gupta C; Fisher S; Story-Roller E; Galanis C; Parrish N; Lamichhane G
    Future Microbiol; 2017 May; 12(6):473-480. PubMed ID: 28326811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.